Jul 31, 2024 · Inspired by NASA's pioneering material science for rocket engines, MiRus leverages proprietary Rhenium-based alloy MoRe® to revolutionize medicine with safer, more durable implants and less invasive surgeries.

Jan 19, 2023 · MiRus LLC is a rapidly growing medical device company located in Marietta GA (about 20 min NW of Atlanta). Join an innovative team with a proven track record of successful commercialization of groundbreaking medical products.

MiRus is dedicated to creating innovative treatments for patients suffering from debilitating diseases. To accomplish this goal, we collaborate with the world’s best surgeons and doctors, hire gifted people and provide them with ample resources to solve complex problems.

MiRus™ is focused on the design of innovative solutions for treatment of spine, orthopedic and structural heart disease with comprehensive solutions to the problems facing surgeons and patients. Get In Touch We're here to help.

Because of our confidence in the science behind the MoRe® alloy technology, MiRus is providing a LIFETIME LIMITED WARRANTY on the MoRe® (Molybdenum-Rhenium) Rods implanted for the duration of the patient's life.

ATLANTA- August 31, 2021 – MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody.

ATLANTA- July 27, 2021 – MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its …

Atlanta – March 28, 2025 – MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel™ 8-Fr aortic transcatheter heart valve (THV). The first two cases were successfully performed this week by Pradeep K. Yadav MD, Director of Structural Interventions, and Vinod H. Thourani MD, Marcus Chairman of ...

Atlanta – July 31, 2024 – MiRus has received Breakthrough Device Designation from the FDA for the EUROPA® Posterior Cervical System, based on it’s proprietary rhenium alloys, for treatment of the cervical and upper thoracic spine.

ATLANTA — February 22, 2021—MiRus announced today that they will offer a LIFETIME LIMITED WARRANTY on its Molybdenum-Rhenium ( MoRe®) superalloy rod technology. The warranty will cover full replacement of the MoRe® Rod and corresponding MiRus hardware used in spinal fusion cases should the MoRe® Rod fracture.